Anuh Pharma Limited (ANUHPHR) Stock Statistics & Valuation Metrics

Anuh Pharma Limited has a market cap or net worth of ₹7.31B. The enterprise value is ₹7.62B.

Anuh Pharma Limited has 100,224,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Anuh Pharma Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 13.02%.

The current PE Ratio of Anuh Pharma Limited is 18.9. Anuh Pharma Limited’s PEG ratio is -0.77.

In the last 12 months, Anuh Pharma Limited had revenue of 6.62B and earned 473.52M in profits. Earnings per share was 4.72.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Anuh Pharma Limited pays an annual dividend of ₹1.5, resulting in a dividend yield of 1.92%

Anuh Pharma Limited upcoming earnings date is Feb 6, 2026, TBA (Confirmed).

Anuh Pharma Limited as a current ratio of 2.11, with Debt / Equity ratio of ―

In the past 12 months, Anuh Pharma Limited has paid 136.53M in taxes.

Anuh Pharma Limited EV to EBITDA ratio is 10.83, with an EV/FCF ratio of 44.88.

Anuh Pharma Limited has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 8.59%, and net profit margin of 7.16%.

The average price target for Anuh Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―